Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens
- Status
- COMPLETED
- Phase
- PHASE2
Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
UMCC 9901: Phase II Study of Tailored-Dose Docetaxel + Trastuzumab in Her-2 Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE3
Docetaxel and Capecitabine in Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Avastin and Taxotere for Esophagogastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE3
ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3